Heterogeneity of Executive Function Abilities in Recently Detoxified Patients with Alcohol Use Disorder: Evidence from a Cluster Analysis

被引:8
作者
Schmid, Franca [1 ]
Benzerouk, Farid [1 ,2 ]
Barriere, Sarah [2 ]
Henry, Audrey [1 ,2 ]
Limosin, Frederic [3 ,4 ,5 ]
Kaladjian, Arthur [1 ,2 ]
Gierski, Fabien [1 ,2 ,6 ]
机构
[1] Univ Reims, Lab Cognit Sante, Soc C2S EA 6291, Reims, France
[2] Pole Univ Psychiat, CHU Reims, EPSM Marne, Reims, France
[3] Univ Paris, Paris Descartes Fac Med, Paris, France
[4] Ctr Univ Paris, Hop Europeen Georges Pompidou, AP HP, Dept Psychiat, Paris, France
[5] Univ Paris, Inst Psychiat & Neurosci Paris IPNP, UMR S1266, INSERM, Paris, France
[6] Univ Picardie Jules Verne, Grp Rech Alcool & Pharmacodependances, INSERM U1247 GRAP, Amiens, France
来源
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH | 2021年 / 45卷 / 01期
关键词
Alcohol Use Disorder; Cluster Analysis; Executive Functions; Heterogeneity; Neuropsychology; WORKING-MEMORY; FRONTAL-LOBE; GO/NO-GO; ADDICTION; DEPENDENCE; KORSAKOFF; FRAMEWORK; DIFFICULTIES; DYSFUNCTION; INHIBITION;
D O I
10.1111/acer.14517
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Impairments of executive functions (EF) have been consistently reported in patients with alcohol use disorder (AUD), mostly in studies which were based on comparisons of means between groups. However, given the high heterogeneity in AUD patients, this approach could actually cover a wide range of EF patterns. In the present study, we addressed the paucity of the literature about cognitive heterogeneity in AUD by applying a cluster analytical approach on EF measures. Methods Seventy-eight withdrawn AUD patients and 77 healthy Control participants completed measures targeting a variety of EF components. We then used cluster analysis to identify subgroups of AUD patients. Furthermore, the AUD subgroups were compared to the Control group to establish their specific EF patterns. Results Findings showed that AUD patients could be divided into 3 clusters based on their EF performances. A first cluster accounting for half of the AUD sample was characterized by unimpaired EF (Cluster 1). The 2 other clusters displayed major EF deficits but differed regarding the deficient EF component. While Cluster 2 was mainly impaired on measures of rule deduction and mental flexibility, Cluster 3 was mainly characterized by a lower processing speed and impaired inhibition of an ongoing motor response. Differences in EF performances of AUD patients could be related to differences in premorbid cognitive reserve, impulsiveness patterns, and withdrawal complications. Conclusions This study highlights the importance of the cognitive heterogeneity in AUD by showing that AUD patients display substantially different EF patterns. Future studies should try to go beyond mere group comparisons to further deepen our understanding about cognitive differences between AUD patients. In the long run, this could lead to more personalized prevention and treatment programs specifically tailored to the patient's impairments.
引用
收藏
页码:163 / 173
页数:11
相关论文
共 50 条
[41]   The Impact of Abstinence From Alcohol on Erectile Dysfunction: A Prospective Follow up in Patients With Alcohol Use Disorder [J].
Karunakaran, Aravind ;
Michael, Jaimon Plathottathil .
JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04) :581-589
[42]   Assessment of Executive Function in Patients With Substance Use Disorder: A Comparison of Inventory- and Performance-Based Assessment [J].
Hagen, Egon ;
Erga, Aleksander H. ;
Hagen, Katrin P. ;
Nesvag, Sverre M. ;
McKay, James R. ;
Lundervold, Astri J. ;
Walderhaug, Espen .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2016, 66 :1-8
[43]   Executive functioning in addicts following health mobile cognitive stimulation Evidence from alcohol and heroin patients [J].
Gamito, P. ;
Oliveira, J. ;
Lopes, P. ;
Morais, D. ;
Brito, R. ;
Cristovao, S. ;
Cacoete, C. ;
Henriques, E. ;
Silva, D. ;
Silva, A. ;
Rebelo, S. ;
Bastos, A. ;
Deus, A. .
PROCEEDINGS OF THE 2013 7TH INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING TECHNOLOGIES FOR HEALTHCARE AND WORKSHOPS (PERVASIVEHEALTH 2013), 2013, :385-388
[44]   Rate of Consumption as a Marker for Alcohol Use Disorder Risk: Evidence From a Human Laboratory Model [J].
Gowin, Joshua ;
Sloan, Matthew ;
Stangl, Bethany ;
Stoddard, Joel ;
Vatsalya, Vatsalya ;
Ramchandani, Vijay .
NEUROPSYCHOPHARMACOLOGY, 2016, 41 :S266-S267
[45]   The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis [J].
Sicignano, Dakota ;
Hernandez, Adrian V. ;
Schiff, Benjamin ;
Elmahy, Nawal ;
White, C. Michael .
CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (02) :293-302
[46]   Alcohol use disorders in patients with bipolar disorder: a systematic review and meta-analysis [J].
Pedro, Maria Olivia Pozzolo ;
Pedro, Manoela Pozzolo ;
Martins, Silvia S. ;
Castaldelli-Maia, Joao Mauricio .
INTERNATIONAL REVIEW OF PSYCHIATRY, 2023, :450-460
[47]   Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence [J].
Mosoni, Carolina ;
Dionisi, Tommaso ;
Vassallo, Gabriele Angelo ;
Mirijello, Antonio ;
Tarli, Claudia ;
Antonelli, Mariangela ;
Sestito, Luisa ;
Rando, Maria Margherita ;
Tosoni, Alberto ;
De Cosmo, Salvatore ;
Gasbarrini, Antonio ;
Addolorato, Giovanni .
FRONTIERS IN PSYCHIATRY, 2018, 9
[48]   Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis [J].
Roerecke, Michael ;
Rehm, Juergen .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014, 43 (03) :906-919
[49]   Cognitive deficits among patients with either gambling disorder or substance use disorders: A cluster analysis [J].
Lucidi, Lorenza ;
Pettorruso, Mauro ;
Bubbico, Giovanna ;
Di Carlo, Francesco ;
Mosca, Alessio ;
Martinotti, Giovanni .
JOURNAL OF BEHAVIORAL ADDICTIONS, 2023, 12 :59-59
[50]   Association of Thiamine Use with Outcomes in Patients with Sepsis and Alcohol Use Disorder: An Analysis of the MIMIC-III Database [J].
Hu, Chang ;
Wu, Tong ;
Ma, Siqing ;
Huang, Weipeng ;
Xu, Qiancheng ;
Kashani, Kianoush B. ;
Hu, Bo ;
Li, Jianguo .
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) :771-786